Wells Fargo Upgrades Zimmer Biomet Holdings to Overweight, Raises Price Target to $123
Benzinga Newsdesk 15 hours ago
Analyst RatingsNewsUpgradesPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Wells Fargo analyst Larry Biegelsen upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Equal-Weight to Overweight and raises the price target from $113 to $123.
Wells Fargo analyst Larry Biegelsen upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Equal-Weight to Overweight and raises the price target from $113 to $123.
